Role of the endothelium in inflammatory bowel diseases.
暂无分享,去创建一个
J Michael Mathis | G. V. Chaitanya | D. Granger | J. Mathis | J. Alexander | J Steven Alexander | W. Cromer | Walter E Cromer | Daniel N Granger | Ganta V Chaitanya
[1] J. Elrod,et al. Reciprocal Regulation of Endothelial Substrate Adhesion and Barrier Function , 2001, Microcirculation.
[2] K. Lundin,et al. Cytokine profiles of cultured microvascular endothelial cells from the human intestine , 1998, Gut.
[3] D. Binion,et al. Butyrate modulates gene and protein expression in human intestinal endothelial cells. , 2003, Biochemical and biophysical research communications.
[4] T. Pufe,et al. Expression of VEGF121 and VEGF165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage , 2002, Journal of anatomy.
[5] B. Jeppsson,et al. p38 Mitogen‐activated protein kinase signalling regulates vascular inflammation and epithelial barrier dysfunction in an experimental model of radiation‐induced colitis , 2010, The British journal of surgery.
[6] A. Gewirtz,et al. Toll like receptor-5: protecting the gut from enteric microbes , 2008, Seminars in Immunopathology.
[7] J. Alexander,et al. H(2)O(2)-mediated permeability II: importance of tyrosine phosphatase and kinase activity. , 2001, American journal of physiology. Cell physiology.
[8] M. Krzystek-Korpacka,et al. Clinical relevance of circulating midkine in ulcerative colitis , 2009, Clinical chemistry and laboratory medicine.
[9] M. Grisham,et al. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[10] J. Sun,et al. IFN-gamma and TNF-alpha induce redistribution of PECAM-1 (CD31) on human endothelial cells. , 1995, Journal of immunology.
[11] A. Gasbarrini,et al. Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for Inflammatory bowel disease treatment , 2009, Cell adhesion & migration.
[12] J. Davis,et al. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. , 1997, The Journal of pharmacology and experimental therapeutics.
[13] D. Shaw,et al. Angiogenesis blockade as a new therapeutic approach to experimental colitis , 2006, Gut.
[14] A. M. Lefer,et al. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. , 1994, The American journal of physiology.
[15] B. Yacyshyn. Adhesion molecule therapeutics in IBD. , 2008, Inflammatory bowel diseases.
[16] K. Rubin,et al. Pericytes as collagen-producing cells in excessive dermal scarring. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[17] E. Dejana,et al. Immune Regulation by Microvascular Endothelial Cells: Directing Innate and Adaptive Immunity, Coagulation, and Inflammation1 , 2007, The Journal of Immunology.
[18] S. Danese,et al. Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens , 2007, The American Journal of Gastroenterology.
[19] S. Akira,et al. Deletion of TLR5 results in spontaneous colitis in mice. , 2007, The Journal of clinical investigation.
[20] S. Miura,et al. Neutrophil elastase in colitis: more than a marker of disease activity? , 2006, Journal of gastroenterology.
[21] D. Veale,et al. Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis , 2005, Current rheumatology reports.
[22] J. S. Alexander. Extracellular matrix, junctional integrity and matrix metalloproteinase interactions , 2002 .
[23] D. Granger,et al. Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T cells. , 2000 .
[24] K. Papadakis. Chemokines in inflammatory bowel disease , 2004, Current allergy and asthma reports.
[25] The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004 .
[26] R. Löfberg,et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. , 1999 .
[27] E. Kouroumalis,et al. Serum Angiogenin in Inflammatory Bowel Disease , 2004, Digestive Diseases and Sciences.
[28] J. Gu,et al. COX-2 expression and tumor angiogenesis in colorectal cancer. , 2004, World Journal of Gastroenterology.
[29] T. Koepsell,et al. Coffee and alcohol use and the risk of ulcerative colitis. , 1989, The American journal of gastroenterology.
[30] A. Michalsen,et al. Activated innate immune system in irritable bowel syndrome? , 2007, Gut.
[31] P. Choi,et al. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. , 1994, Gut.
[32] Shuji Ogino,et al. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.
[33] B. Scallon,et al. Validation of the interleukin‐10 knockout mouse model of colitis: antitumour necrosis factor‐antibodies suppress the progression of colitis , 2003, Clinical and experimental immunology.
[34] D. Binion,et al. Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation. , 2003, Gastroenterology.
[35] J. Tabibian,et al. Local Thrombolysis: A Newer Approach to Treating Inflammatory Bowel Disease-related Thromboembolism , 2009, Journal of clinical gastroenterology.
[36] J. Gisbert,et al. Gastric angiogenesis and Helicobacter pylori infection. , 2006, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[37] Susumu Ishida,et al. VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. , 2004, Investigative ophthalmology & visual science.
[38] H. Verspaget,et al. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[39] C. Mirabelli,et al. The link between inflammatory disease and patterns of leukocyte recruitment. , 1998, Expert opinion on investigational drugs.
[40] M. Sans,et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. , 2009, Gastroenterology.
[41] M. Krzystek-Korpacka,et al. Platelet-derived growth factor-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel disease. , 2009, Clinical biochemistry.
[42] H. Blau,et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.
[43] T. Muramatsu,et al. Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by Midkine. , 2000, Journal of biochemistry.
[44] T. Imaizumi,et al. Regulation of CX3CL1/fractalkine expression in endothelial cells. , 2004, Journal of atherosclerosis and thrombosis.
[45] T. Joh,et al. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis. , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[46] J. Folkman,et al. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. , 2006, Experimental cell research.
[47] J. Langhorst,et al. Stress-related peripheral neuroendocrine–immune interactions in women with ulcerative colitis , 2007, Psychoneuroendocrinology.
[48] Y. Wen,et al. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. , 1999, Investigative ophthalmology & visual science.
[49] K. Ley,et al. GASTROENTEROLOGY 2006;131:1518–1529 Antibody Blockade of CCL25/CCR9 Ameliorates Early but not Late Chronic , 2022 .
[50] E. Masini,et al. Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine , 1997, Inflammation Research.
[51] J. Isner,et al. Divergence of Angiogenic and Vascular Permeability Signaling by VEGF: Inhibition of Protein Kinase C Suppresses VEGF-Induced Angiogenesis, but Promotes VEGF-Induced, NO-Dependent Vascular Permeability , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[52] D. Podolsky,et al. Growth factors in inflammatory bowel disease. , 1999, Inflammatory bowel diseases.
[53] S. Walsh,et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. , 2001, The American journal of pathology.
[54] D. Carden,et al. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. , 1998, American journal of physiology. Heart and circulatory physiology.
[55] Jacques Landry,et al. Vascular Endothelial Growth Factor (VEGF)-driven Actin-based Motility Is Mediated by VEGFR2 and Requires Concerted Activation of Stress-activated Protein Kinase 2 (SAPK2/p38) and Geldanamycin-sensitive Phosphorylation of Focal Adhesion Kinase* , 2000, The Journal of Biological Chemistry.
[56] H. Sudhoff,et al. Salivary VEGF: a non-invasive angiogenic and lymphangiogenic proxy in head and neck cancer prognostication , 2008, International archives of medicine.
[57] Xueli Yuan,et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.
[58] T. Muramatsu,et al. Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. , 2002, Journal of cell science.
[59] R. Pierce,et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.
[60] D. Binion,et al. Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX‐2 inhibition , 2003, FEBS letters.
[61] D. Binion,et al. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition , 2008, Gut.
[62] M. Sans,et al. VCAM-1, but Not ICAM-1 or MAdCAM-1, Immunoblockade Ameliorates DSS-Induced Colitis in Mice , 2000, Laboratory Investigation.
[63] M. Zago,et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. , 2008, Experimental hematology.
[64] A. Bousvaros,et al. Serum Basic Fibroblast Growth Factor in Pediatric Crohn's Disease (Implications for Wound Healing) , 1997, Digestive Diseases and Sciences.
[65] A. Sckell,et al. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice , 2006, BMC Cancer.
[66] M. Parkes,et al. Contribution of the IL‐2 and IL‐10 genes to inflammatory bowel disease (IBD) susceptibility , 1998, Clinical and experimental immunology.
[67] B. Siegmund. Targeted Therapies in Inflammatory Bowel Disease , 2009, Digestive Diseases.
[68] M. Sans,et al. The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease , 2009, European journal of immunology.
[69] S. Koch,et al. Expression of IL-12-related molecules in human intestinal microvascular endothelial cells is regulated by TLR3. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[70] K. Takeuchi,et al. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[71] R. Shaker,et al. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC). , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[72] S. Danese,et al. The Role of JAM‐A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind , 2009, Annals of the New York Academy of Sciences.
[73] T. Oshima,et al. H(2)O(2)-mediated permeability: role of MAPK and occludin. , 2000, American journal of physiology. Cell physiology.
[74] D. Latinne,et al. Intestinal helminths: a clue explaining the low incidence of inflammatory bowel diseases in Subsaharan Africa? Potential benefits and hazards of helminth therapy. , 2006, Acta gastro-enterologica Belgica.
[75] T. Ishikawa,et al. Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. , 2010, Carcinogenesis.
[76] S. Targan,et al. Biologic therapy of inflammatory bowel disease. , 2002, Gastroenterology.
[77] J. Timmermans,et al. Influence of soluble guanylate cyclase inhibition on inflammation and motility disturbances in DSS-induced colitis. , 2008, European journal of pharmacology.
[78] K. Stokes,et al. Role of blood- and tissue-associated inducible nitric-oxide synthase in colonic inflammation. , 2007, The American journal of pathology.
[79] U. Förstermann. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal , 2006, Biological chemistry.
[80] Paul Rutgeerts,et al. CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn's disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue , 2004, European journal of immunology.
[81] R. Dweik,et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[82] G. Porro,et al. The vascularity of internal fistulae in Crohn's disease: an in vivo power Doppler ultrasonography assessment , 2002, Gut.
[83] K Miyamoto,et al. VEGF increases retinal vascular ICAM-1 expression in vivo. , 1999, Investigative ophthalmology & visual science.
[84] G. Kaplan,et al. The Role of TNFα in Ulcerative Colitis , 2007 .
[85] T. Kucharzik,et al. Human intestinal epithelial cells down‐regulate IL‐8 expression in human intestinal microvascular endothelial cells; role of transforming growth factor‐beta 1 (TGF‐β1) , 1998, Clinical and experimental immunology.
[86] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[87] Y. Wang,et al. Madcam‐1 Expression and Regulation in Murine Colonic Endothelial Cells in Vitro , 2005, Inflammatory bowel diseases.
[88] J. P. McCoy,et al. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. , 2005, Blood.
[89] T. Oshima,et al. Regulation and distribution of MAdCAM-1 in endothelial cells in vitro. , 2001, American journal of physiology. Cell physiology.
[90] H. Ogata,et al. Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis , 2006, Journal of Gastroenterology.
[91] R. Russell,et al. Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. , 1993, Gut.
[92] S. Veldhuyzen van Zanten,et al. Therapeutic Role for Bismuth Compounds in TNBS-Induced Colitis in the Rat , 2000, Digestive Diseases and Sciences.
[93] P. Jani,et al. Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier , 2006, British Journal of Ophthalmology.
[94] J. Haerting,et al. Anti-angiogenic therapies for metastatic colorectal cancer. , 2009, The Cochrane database of systematic reviews.
[95] F. Rosendaal,et al. Mutations in Clotting Factors and Inflammatory Bowel Disease , 2007, The American Journal of Gastroenterology.
[96] J. Ambati,et al. Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels , 2009, Nature Medicine.
[97] I. Sasaki,et al. Remodeling of Vascular Wall in Crohn's Disease , 1999, Digestive Diseases and Sciences.
[98] M. Yaar,et al. UV induces VEGF through a TNF‐α‐independent pathway , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[99] K. Conlon,et al. COX-2, VEGF and tumour angiogenesis. , 2009, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[100] B. Sands. Inflammatory bowel disease: past, present, and future , 2007, Journal of Gastroenterology.
[101] A. Gewirtz. Flag in the crossroads: flagellin modulates innate and adaptive immunity , 2006, Current opinion in gastroenterology.
[102] J. Willis,et al. CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-cell transmigration. , 2004, Gastroenterology.
[103] T. Oshima,et al. TNF-α induced endothelial MAdCAM-1 expression is regulated by exogenous, not endogenous nitric oxide , 2001, BMC gastroenterology.
[104] P. Elliott,et al. Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome. , 1999, Methods in enzymology.
[105] D. Binion,et al. Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[106] T. Moreels,et al. Gastrointestinal Parasites: Potential Therapy for Refractory Inflammatory Bowel Diseases , 2005, Inflammatory bowel diseases.
[107] D. Ostanin,et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[108] Hyung Jin Kim,et al. Vascular Endothelial Growth Factor Expression of Intercellular Adhesion Molecule 1 (ICAM-1), Vascular Cell Adhesion Molecule 1 (VCAM-1), and E-selectin through Nuclear Factor-κB Activation in Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[109] M. Taketo,et al. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. , 2002, Cancer research.
[110] D. Binion,et al. Vascular cell adhesion molecule-1 expression in human intestinal microvascular endothelial cells is regulated by PI 3-kinase/Akt/MAPK/NF-kappaB: inhibitory role of curcumin. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[111] J. Alexander,et al. Role of cadherin internalization in hydrogen peroxide-mediated endothelial permeability. , 1998, Free radical biology & medicine.
[112] M. Fukuda,et al. Role of sulfated O-glycans expressed by high endothelial venule-like vessels in pathogenesis of chronic inflammatory gastrointestinal diseases. , 2009, Biological & pharmaceutical bulletin.
[113] J. Loscalzo,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.
[114] R. Stockbrügger,et al. Differential Behavior of Coagulation Factor XIII in Patients with Inflammatory Bowel Disease and in Patients with Giant Cell Arteritis , 1999, Pathophysiology of Haemostasis and Thrombosis.
[115] S. Kawachi,et al. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[116] V. Orlova,et al. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin–mediated cell–cell contacts , 2006, The Journal of experimental medicine.
[117] D. Binion,et al. Mesenteric venous thrombosis in inflammatory bowel disease , 2003, American Journal of Gastroenterology.
[118] F. Brennan,et al. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis , 2003, Gut.
[119] Hua-Lin Wu,et al. Angiostatin antagonizes the action of VEGF-A in human endothelial cells via two distinct pathways. , 2003, Biochemical and biophysical research communications.
[120] V. Ganta,et al. Angiopoietin‐2 in experimental colitis , 2010, Inflammatory bowel diseases.
[121] Z. Serfőző,et al. Effect of IBD sera on expression of inducible and endothelial nitric oxide synthase in human umbilical vein endothelial cells. , 2006, World journal of gastroenterology.
[122] J. Alexander,et al. Density-dependent control of MAdCAM-1 and chronic inflammation. Focus on "Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells". , 2005, American journal of physiology. Cell physiology.
[123] N. Ziats,et al. Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease , 1998, The Lancet.
[124] A. Grodzinsky,et al. Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. , 2004, The American journal of pathology.
[125] F. Brennan,et al. IL-10 gene therapy prevents TNBS-induced colitis , 2002, Gene Therapy.
[126] L. Claesson‐Welsh,et al. VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.
[127] K. Chadee,et al. Biologic Therapies Against Inflammatory Bowel Disease: A Dysregulated Immune System and the Cross Talk with Gastrointestinal Mucosa Hold the Key , 2008 .
[128] E. Dejana,et al. The role of junctional adhesion molecules in vascular inflammation , 2007, Nature Reviews Immunology.
[129] Giuseppe Cirino,et al. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage , 2009, Proceedings of the National Academy of Sciences.
[130] A. Gasbarrini,et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. , 2006, Gastroenterology.
[131] D. Veale,et al. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. , 2006, Best practice & research. Clinical rheumatology.
[132] T. Macdonald,et al. Characterization of the mucosal cell‐mediated immune response in IL‐2 knockout mice before and after the onset of colitis , 1997, Immunology.
[133] Yanbing Ma,et al. Targeting TGF‐&bgr;1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis , 2010, Inflammatory bowel diseases.
[134] R. Tersigni,et al. TGF‐β1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis , 2003 .
[135] W. Sessa. Molecular control of blood flow and angiogenesis: role of nitric oxide , 2009, Journal of thrombosis and haemostasis : JTH.
[136] U. Förstermann,et al. Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace , 2006, Circulation.
[137] D. Granger,et al. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. , 2001, Microvascular research.
[138] M. Dubinsky,et al. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. , 2000, Radiology.
[139] K. Matsushima,et al. CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process1 , 2008, The Journal of Immunology.
[140] A. Minagar,et al. Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α , 2005, BMC Physiology.
[141] N. Senninger,et al. PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[142] C. Mackay,et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. , 1997, The American journal of pathology.
[143] C. A. de la Motte,et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. , 2003, Gastroenterology.
[144] J. Loscalzo,et al. Molecular Mechanisms Underlying the Proangiogenic Effect of Factor XIII , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[145] A. Schanaider,et al. Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production. , 2007, World journal of gastroenterology.
[146] H. Augustin,et al. Angiopoietins: a link between angiogenesis and inflammation. , 2006, Trends in immunology.
[147] W. H. Percy,et al. Experimental colitis increases blood-brain barrier permeability in rabbits. , 1999, The American journal of physiology.
[148] K. Ley,et al. Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis , 2006, The Journal of experimental medicine.
[149] K. Geboes,et al. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease , 2006, Inflammatory bowel diseases.
[150] M. Ladomery,et al. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors , 2008, Journal of Cell Science.
[151] S. Harper,et al. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor , 2005, Diabetologia.
[152] F. Magro,et al. Soluble Selectins, sICAM, sVCAM, and Angiogenic Proteins in Different Activity Groups of Patients with Inflammatory Bowel Disease , 2004, Digestive Diseases and Sciences.
[153] M. Neurath,et al. Specific Regulation of T Helper Cell 1–mediated Murine Colitis by CEACAM1 , 2004, The Journal of experimental medicine.
[154] C. Fiocchi,et al. Intestinal fibrosis in IBD—a dynamic, multifactorial process , 2009, Nature Reviews Gastroenterology &Hepatology.
[155] A. Patzak,et al. eNOS involved in colitis-induced mucosal blood flow increase. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[156] T. Imai,et al. Chemokines as Novel Therapeutic Targets for Inflammatory Bowel Disease , 2009, Annals of the New York Academy of Sciences.
[157] H. Ogata,et al. Novel pathophysiological concepts of inflammatory bowel disease , 2005, Journal of Gastroenterology.
[158] R. Srirajaskanthan,et al. Venous thrombosis in inflammatory bowel disease , 2005, European journal of gastroenterology & hepatology.
[159] S. Szabó,et al. Neutralizing Anti-Vascular Endothelial Growth Factor (VEGF) Antibody Reduces Severity of Experimental Ulcerative Colitis in Rats: Direct Evidence for the Pathogenic Role of VEGF , 2009, Journal of Pharmacology and Experimental Therapeutics.
[160] Christopher P. Johnson,et al. Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling , 2004, Cell Communication and Signaling.
[161] T. Pincus,et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. , 2009, Arthritis and rheumatism.
[162] J. P. McCoy,et al. A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile , 2007, BMC Immunology.
[163] Holger Gerhardt,et al. VEGFRs and Notch: a dynamic collaboration in vascular patterning. , 2009, Biochemical Society transactions.
[164] S. Fais,et al. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. , 1995, Gastroenterology.
[165] M. Röcken,et al. Angiogenesis drives psoriasis pathogenesis , 2009, International journal of experimental pathology.
[166] P. Colville-Nash,et al. THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN A MURINE CHRONIC GRANULOMATOUS TISSUE AIR POUCH MODEL OF ANGIOGENESIS , 1996, The Journal of pathology.
[167] Andreas Schober,et al. Chemokines in Atherosclerosis , Thrombosis , and Vascular Biology Series , 2008 .
[168] J. Wallace,et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.
[169] A. Gewirtz,et al. Activation of toll‐like receptor 3 protects against DSS‐induced acute colitis , 2007, Inflammatory bowel diseases.
[170] D. Binion,et al. Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. , 2000, Free radical biology & medicine.
[171] M. Aurrand-Lions,et al. Angiogenesis and inflammation face off , 2006, Nature Medicine.
[172] M. Franco,et al. Effect of COX-2 inhibitor after TNBS-induced colitis in wistar rats , 2009, Journal of Molecular Histology.
[173] M. Taketo,et al. COX selectivity and animal models for colon cancer. , 2002, Current pharmaceutical design.
[174] G. Banfalvi,et al. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease , 2005, Scandinavian journal of gastroenterology.
[175] M. Teixeira,et al. Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. , 2009, Microvascular research.
[176] S. Danese,et al. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. , 2008, The American journal of pathology.
[177] M. Vatn,et al. Increased number and activation of colonic macrophages in pediatric patients with untreated Crohn's disease , 2009, Inflammatory bowel diseases.
[178] S. Kanazawa,et al. VEGF, basic-FGF, and TGF-β in Crohn’s disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation , 2001 .
[179] T. Hovig,et al. Isolation and longterm culture of human intestinal microvascular endothelial cells. , 1995, Gut.
[180] K. Suzawa,et al. GlcNAc6ST‐1‐mediated decoration of MAdCAM‐1 protein with L‐selectin ligand carbohydrates directs disease activity of ulcerative colitis , 2009, Inflammatory bowel diseases.
[181] Young Sook Park. [COX-2 inhibitors in inflammatory bowel disease: friends or foes?]. , 2007, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.
[182] D. Lefer,et al. Increased disease activity in eNOS-deficient mice in experimental colitis. , 2003, Free radical biology & medicine.
[183] A. De Benedetti,et al. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis , 1996, International journal of cancer.
[184] D. Latinne,et al. New insights into the cellular immunology of the intestine in relation to the pathophysiology of inflammatory bowel diseases. , 2006, Acta gastro-enterologica Belgica.
[185] K. Pritchard,et al. Mechanisms of Endotoxin Tolerance in Human Intestinal Microvascular Endothelial Cells 1 , 2003, The Journal of Immunology.
[186] P. Brandtzaeg,et al. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. , 1996, Journal of immunology.
[187] S. Szabó,et al. Mesalamine Restores Angiogenic Balance in Experimental Ulcerative Colitis by Reducing Expression of Endostatin and Angiostatin: Novel Molecular Mechanism for Therapeutic Action of Mesalamine , 2009, Journal of Pharmacology and Experimental Therapeutics.
[188] C. Pothoulakis,et al. The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[189] C. Moskaluk,et al. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice. , 2001, Gastroenterology.
[190] M. Tzardi,et al. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[191] A. Chan. Can aspirin prevent colorectal cancer? , 2007, The Lancet.
[192] R. Hershkoviz,et al. Amelioration of experimental colitis by thalidomide. , 2001, The Israel Medical Association journal : IMAJ.
[193] D. Binion,et al. Human Intestinal Microvascular Endothelial Cells Express Toll-Like Receptor 5: A Binding Partner for Bacterial Flagellin , 2004, The Journal of Immunology.
[194] M. Sans,et al. 123Iodine-labelled anti-VCAM-1 antibody scintigraphy in the assessment of experimental colitis , 2001, European journal of gastroenterology & hepatology.
[195] P. Malfertheiner,et al. Oxidative stress in ulcerative colitis-associated carcinogenesis. , 2008, Pathology, research and practice.
[196] R. D'Incà,et al. Reduced Endothelial Progenitor Cell Number and Function in Inflammatory Bowel Disease: A Possible Link to the Pathogenesis , 2009, The American Journal of Gastroenterology.
[197] D. Ota,et al. Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2* , 2003, The Journal of Biological Chemistry.
[198] D. Jewell,et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. , 1988, Gut.
[199] E. Berardesca,et al. Effective Therapy with Anti‐TNF‐α in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin Lesions , 2007, Annals of the New York Academy of Sciences.
[200] Qiang Shen,et al. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation , 2009, Expert Reviews in Molecular Medicine.
[201] E. Maltezos,et al. Vascular endothelial growth factor in inflammatory bowel disease , 2003, International Journal of Colorectal Disease.
[202] T. Aikou,et al. Serum midkine levels are increased in patients with various types of carcinomas , 2000, British Journal of Cancer.
[203] A. Gasbarrini,et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients , 2003, Gut.
[204] A. Zuercher,et al. Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host. , 2004, Vaccine.
[205] P. Tak,et al. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints , 2008, Annals of the rheumatic diseases.
[206] C. A. de la Motte,et al. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. , 2007, Gastroenterology.
[207] D. Binion,et al. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[208] Christopher P. Johnson,et al. Cyclosporine A Enhances Leukocyte Binding by Human Intestinal Microvascular Endothelial Cells through Inhibition of p38 MAPK and iNOS , 2002, The Journal of Biological Chemistry.
[209] Wendy S. Garrett,et al. Communicable Ulcerative Colitis Induced by T-bet Deficiency in the Innate Immune System , 2007, Cell.
[210] A. Loukas,et al. Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer? , 2008, Clinical & developmental immunology.
[211] J. Martin Collinson,et al. Corneal avascularity is due to soluble VEGF receptor-1 , 2006, Nature.
[212] T. Muramatsu. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. , 2002, Journal of biochemistry.
[213] M. Yaqoob,et al. New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups. , 2006, Journal of immunological methods.
[214] Y. Mori,et al. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. , 2001, Circulation research.
[215] A. Mazar,et al. Differential angiogenic regulation of experimental colitis. , 2006, The American journal of pathology.
[216] A. Gutzeit,et al. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. , 1999, European journal of gastroenterology & hepatology.
[217] J. Alexander,et al. VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[218] A. Bousvaros,et al. Elevated Serum Vascular Endothelial Growth Factor in Children and Young Adults with Crohn's Disease , 1999, Digestive Diseases and Sciences.
[219] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[220] R. Ginnan,et al. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. , 2008, Free radical biology & medicine.
[221] F. Luscinskas,et al. Monocytes Induce Reversible Focal Changes in Vascular Endothelial Cadherin Complex during Transendothelial Migration under Flow , 2000, The Journal of cell biology.
[222] S. Szabó,et al. Altered angiogenic balance in ulcerative colitis: a key to impaired healing? , 2006, Biochemical and biophysical research communications.
[223] M. Hristov,et al. Adult progenitor cells in vascular remodeling during atherosclerosis , 2008, Biological chemistry.
[224] J. Wallace,et al. Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. , 1995, Journal of pharmacological and toxicological methods.
[225] D. Binion,et al. The Intestinal Microvasculature as a Therapeutic Target in Inflammatory Bowel Disease , 2006, Annals of the New York Academy of Sciences.
[226] M. Reed,et al. CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis , 2009, Journal of cellular physiology.
[227] M. Denis,et al. ADAM15 upregulation and interaction with multiple binding partners in inflammatory bowel disease , 2006, Laboratory Investigation.
[228] R. Hobson,et al. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. , 2003, American journal of physiology. Heart and circulatory physiology.
[229] L. Mayer,et al. Evolving paradigms in the pathogenesis of IBD , 2009, Journal of Gastroenterology.
[230] G. Hospers,et al. Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor , 2004, Angiogenesis.
[231] P. Perrin,et al. CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[232] A. Dhillon,et al. Granulomatous vasculitis in Crohn's disease. , 1991, Gastroenterology.
[233] C. Benjamin,et al. Expression of vascular adhesion molecules in inflammatory bowel disease. , 1992, Gastroenterology.